329 related articles for article (PubMed ID: 37865484)
1. Hormonal Injustice: Environmental Toxicants as Drivers of Endocrine Health Disparities.
Weiss MC; Wang L; Sargis RM
Endocrinol Metab Clin North Am; 2023 Dec; 52(4):719-736. PubMed ID: 37865484
[TBL] [Abstract][Full Text] [Related]
2. Disparities in Environmental Exposures to Endocrine-Disrupting Chemicals and Diabetes Risk in Vulnerable Populations.
Ruiz D; Becerra M; Jagai JS; Ard K; Sargis RM
Diabetes Care; 2018 Jan; 41(1):193-205. PubMed ID: 29142003
[TBL] [Abstract][Full Text] [Related]
3. The Minderoo-Monaco Commission on Plastics and Human Health.
Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
[TBL] [Abstract][Full Text] [Related]
4. Environmental neglect: endocrine disruptors as underappreciated but potentially modifiable diabetes risk factors.
Sargis RM; Simmons RA
Diabetologia; 2019 Oct; 62(10):1811-1822. PubMed ID: 31451869
[TBL] [Abstract][Full Text] [Related]
5. Endocrine-Disrupting Chemicals and Breast Cancer: Disparities in Exposure and Importance of Research Inclusivity.
Santaliz Casiano A; Lee A; Teteh D; Madak Erdogan Z; Treviño L
Endocrinology; 2022 May; 163(5):. PubMed ID: 35325096
[TBL] [Abstract][Full Text] [Related]
6. Endocrine-disrupting chemicals: Mainstream recognition of health effects and implications for the practicing internist.
Trasande L; Sargis RM
J Intern Med; 2024 Feb; 295(2):259-274. PubMed ID: 38037246
[TBL] [Abstract][Full Text] [Related]
7. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
[TBL] [Abstract][Full Text] [Related]
8. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
[TBL] [Abstract][Full Text] [Related]
9. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.
Gore AC; Chappell VA; Fenton SE; Flaws JA; Nadal A; Prins GS; Toppari J; Zoeller RT
Endocr Rev; 2015 Dec; 36(6):E1-E150. PubMed ID: 26544531
[TBL] [Abstract][Full Text] [Related]
10. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
J Toxicol Environ Health A; 2020 Jul; 83(13-14):485-494. PubMed ID: 32552445
[TBL] [Abstract][Full Text] [Related]
11. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
[TBL] [Abstract][Full Text] [Related]
12. Human exposure to endocrine disruptors and breast milk.
Stefanidou M; Maravelias C; Spiliopoulou C
Endocr Metab Immune Disord Drug Targets; 2009 Sep; 9(3):269-76. PubMed ID: 19594415
[TBL] [Abstract][Full Text] [Related]
13. Human exposure to endocrine disrupting chemicals: effects on the male and female reproductive systems.
Sifakis S; Androutsopoulos VP; Tsatsakis AM; Spandidos DA
Environ Toxicol Pharmacol; 2017 Apr; 51():56-70. PubMed ID: 28292651
[TBL] [Abstract][Full Text] [Related]
14. Exposure to environmental endocrine disrupting compounds and men's health.
Meeker JD
Maturitas; 2010 Jul; 66(3):236-41. PubMed ID: 20347536
[TBL] [Abstract][Full Text] [Related]
15. Male pubertal development: are endocrine-disrupting compounds shifting the norms?
Zawatski W; Lee MM
J Endocrinol; 2013; 218(2):R1-12. PubMed ID: 23709001
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine and behavioral effects of embryonic exposure to endocrine disrupting chemicals in birds.
Ottinger MA; Lavoie E; Thompson N; Barton A; Whitehouse K; Barton M; Abdelnabi M; Quinn M; Panzica G; Viglietti-Panzica C
Brain Res Rev; 2008 Mar; 57(2):376-85. PubMed ID: 18006066
[TBL] [Abstract][Full Text] [Related]
17. The non-genomic effects of endocrine-disrupting chemicals on mammalian sperm.
Tavares RS; Escada-Rebelo S; Correia M; Mota PC; Ramalho-Santos J
Reproduction; 2016 Jan; 151(1):R1-R13. PubMed ID: 26585413
[TBL] [Abstract][Full Text] [Related]
18. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.
Wan MLY; Co VA; El-Nezami H
Crit Rev Food Sci Nutr; 2022; 62(24):6549-6576. PubMed ID: 33819127
[TBL] [Abstract][Full Text] [Related]
19. Association of Preterm Birth and Exposure to Endocrine Disrupting Chemicals.
Kolan AS; Hall JM
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768276
[TBL] [Abstract][Full Text] [Related]
20. Racial/ethnic disparities in disease burden and costs related to exposure to endocrine-disrupting chemicals in the United States: an exploratory analysis.
Attina TM; Malits J; Naidu M; Trasande L
J Clin Epidemiol; 2019 Apr; 108():34-43. PubMed ID: 30529005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
